Nov 11 (Kyodo) - A Japanese health ministry panel approved Wednesday the administration of third booster shots of U.S. pharmaceutical giant Pfizer Inc.'s COVID-19 vaccine to people aged 18 and over, starting with medical personnel from December.
The move came as overseas studies showed antibodies that protect against the respiratory disease decrease over time in all age groups, with the effectiveness of vaccines lasting around six months.